Lucid Diagnostics Inc. (LUCD) Investor Relations Documents

Lucid Diagnostics Inc. (LUCD) investor relations documents from the company's IR site: 5 presentations, 35 press releases; latest deck 2026-05-14. Read in-app with summaries. First-party data.

https://ir.luciddx.com/image/CLEAN_LUCD_1Q26_Earnings_Webinar_v1.pdf — Lucid Diagnostics Q1 2026 business update reports $1.3M in revenue and 3,177 EsoGuard test volumes, supported by a $16.8M net proceeds public offering.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-04Press releaseLucid Diagnostics to Participate in Upcoming Investor Conferences
2026-05-14Presentationhttps://ir.luciddx.com/image/CLEAN_LUCD_1Q26_Earnings_Webinar_v1.pdf
2026-04-30Press releaseLucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026
2026-04-24Press releaseLucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock
2026-04-23Press releaseLucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock
2026-04-09Press releaseLucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference
2026-04-07Earnings deckhttps://ir.luciddx.com/image/Lucid-Overview-Apr-2026.pdf
2026-03-26Earnings deckhttps://ir.luciddx.com/image/LUCD_4Q25_Earnings_Webinar.pdf
2026-03-26Press releasePDF
2026-03-26Press releaseEarnings Release
2026-01-21Press releaseLucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard®
2025-12-09Press releaseLucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detect
2025-11-20Press releaseLucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree
2025-11-13Press releaseLucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
2025-11-12Presentationhttps://ir.luciddx.com/image/LUCD+3Q25+Earnings+Webinar+.pdf
2025-10-29Press releaseLucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025
2025-10-15Press releaseLucid Diagnostics to Participate in the 2025 Maxim Growth Summit
2025-09-25Press releaseLucid Diagnostics Appoints Healthcare Industry Veteran John R. Palumbo to Board of Directors
2025-09-16Press releaseLucid Diagnostics Appoints Danielle Scelfo as Senior Vice President, Market Access & Government Affairs
2025-09-11Press releaseLucid Diagnostics Announces Closing of Public Offering of Common Stock
2025-09-10Press releaseLucid Diagnostics Announces Pricing of Public Offering of Common Stock
2025-09-09Press releaseLucid Diagnostics Announces Proposed Public Offering of Common Stock
2025-09-05Press releaseLucid Diagnostics to Host Investor Call on Monday, September 8, 2025
2025-08-27Press releaseLucid Diagnostics to Participate in the Cantor Global Healthcare Conference 2025
2025-08-13Presentationhttps://ir.luciddx.com/image/LUCD+2Q25+Earnings+Webinar.pdf
2025-08-05Press releaseLucid Diagnostics to Participate in Upcoming Investor Conferences
2025-07-30Press releaseLucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 13, 2025
2025-07-16Press releaseMolDX to Convene Expert Medical Panel on Medicare Local Coverage Determination (LCD) for Lucid Diagnostics' EsoGuard® Es
2025-06-18Press releaseMajor California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics' EsoG
2025-05-27Press releaseLucid Diagnostics to Join Russell 2000® and Russell 3000® Indexes
2025-04-30Press releaseLucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025
2025-04-24Press releaseNCI-Sponsored Study Shows Positive Data for Lucid Diagnostics' EsoGuard® Esophageal DNA Test in Patients Without Symptom
2025-04-11Press releaseLucid Diagnostics Announces Closing of Public Offering of Common Stock
2025-04-09Press releaseLucid Diagnostics Announces Proposed Public Offering of Common Stock
2025-04-09Press releaseLucid Diagnostics Announces Pricing of Public Offering of Common Stock
2025-04-03Press releaseLucid Diagnostics to Participate in Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference
2025-03-27Press releaseLucid Diagnostics Launches "Embrace the Future" Campaign Showcasing EsoCheck's Groundbreaking Collect+Protect Esophageal
2025-03-24Press releasePDF
2025-03-24Press releaseEarnings Release
2025-03-20Press releaseLucid Diagnostics Announces Updated National Comprehensive Cancer Network® (NCCN) Guidelines Now Include Esophageal Prec

LUCD overview · LUCD earnings · LUCD financials · LUCD KPIs · LUCD ownership · LUCD peers · LUCD filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.